Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 6.1B | 6.8B | 5.4B | 6.6B |
Cost of revenue | 4.7B | 5.9B | 4.1B | 4.7B |
Gross profit | 1.4B | 859M | 1.3B | 1.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 449M | 103M | 195M | -415M |
Operating income | 502M | 348M | 708M | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 118M | 146M | 90M | 147M |
Other income expense | 889M | -51M | 241M | -88M |
Pretax income | 1.3B | 151M | 859M | 1.6B |
Tax provision | 440M | 22M | 6M | 449M |
Net income | 833M | 129M | 850M | 1.2B |
Basic EPS | 2.7 | 0.4 | 2.7 | 3.8 |
Diluted EPS | 2.7 | 0.4 | 2.7 | 3.8 |
Basic average shares | 314M | 313M | 314M | 313M |
Diluted average shares | 314M | 314M | 314M | 314M |
EBITDA | 1.0B | 848M | 1.2B | 2.4B |
Net income from continuing op. | 833M | 129M | 850M | 1.2B |
Minority interests | 6M | -11M | 2M | 4M |
Preferred stock dividends | — | — | — | — |